CLINICAL_TRIALS
trial_result
· 2016-01-28
Clinical Trial Update: Tolvaptan/Ultrafiltration in the Treatment of Acute Heart Failure [Phase 4]
Summary
A Phase 4 clinical trial evaluating tolvaptan with ultrafiltration for acute decompensated heart failure has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Christ Hospital | Conditions: Acute Decompensated Heart Failure | Phase 4 | Status: COMPLETED